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Figure 2. GM 6001 increases meniscal shear strength in the presence
of IL-1. The interfacial shear strength of repair was measured after treat-
ment of meniscal repair model explants with control media, 100 pg/mL
IL-1, 100 pg/mL IL-1 and 200 ng/mL GM 6001, and 100 pg/mL IL-1 and
200 ng/mL GM 6001 negative control (NC GM 6001) for 14 days (n = 9−11
explants per treatment group). The bar indicate the mean shear strength
in kPa + standard error. a: p< 0.0005 compared to control. b: p< 0.05
compared to IL-1 + GM 6001.
Results: Over time in culture there was a slight increase in MMP activity
in control explants, while Il-1 treatment progressively increased MMP
activity (Figure 1). On the other hand, in the presence of Il-1, the broad
spectrum MMP inhibitor GM 6001 signiﬁcantly suppressed MMP activity
in the media (p< 0.005). MMP activity was also reduced in the presence of
Il-1 by the MMP-3 and MMP-8 inhibitors (p< 0.05). Treatment of meniscal
repair model explants with Il-1 signiﬁcantly decreased the shear strength
of repair, as compared to control explants (Figure 2, p< 0.0005). In the
presence of Il-1, GM 6001 increased the shear strength of repair 2.3-
fold over Il-1 treated explants alone (p< 0.05). However, individual MMP
inhibitors did not alter the shear strength of repair in either the presence
or absence of Il-1.
Conclusions: We found that MMPs are responsible for approximately
50% of the Il-1 mediated inhibition of meniscal healing, as shown by
broad-spectrum inhibition of MMP activity. These results suggest that Il-1
may inhibit meniscal repair through the upregulation of MMPs, but the
inhibition of multiple MMPs is necessary to promote integrative meniscal
repair in vitro and potentially in vivo following joint injury or during arthritis.
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Purpose: To investigate morphometric change of cartilage in cMF and
TrF over the ﬁrst two years after acute ACL injury.
Methods: In this longitudinal MRI analysis we assessed a consecu-
tive sub-set of subjects included in an RCT of surgical versus non-
surgical treatment after acute ACL injury (The KANON study). 29 patients
(29 knees, 21 males) with a not more than 4 weeks old ACL rupture
were assessed by MRI and underwent similar extensive rehabilitation. 19
of these subjects (mean age 28, 95%CI, 26−30 y) in addition underwent
an ACL reconstruction within 7w from injury, while 10 (mean age 25,
95%CI 21−29 y) were treated with rehabilitation alone. MRI scans were
performed using a 1.5 T imager with a circular polarized surface coil at
baseline, 3 and 24 months after injury. A quantitative analysis was per-
formed where a multi-spectral image data set was created and computer
analyzed. To avoid artefact bias (i.e. ﬁxation material in group treated with
ACL reconstruction), change was measured from 3 to 24 months. We
quantiﬁed cartilage volume (VC), thickness (ThCcAB) and surface area
(AC) in cMF and TrF. Change was reported as mean change, percent
change and standard response mean (SRM, mean change divided by
the standard deviation of change).
Results: In cMF, cartilage morphometry measures increased from
3−24 months after injury (0.052<SRM>0.750). Mean cartilage thickness
and volume increased with 4.2% (95%CI, 2.1−6.3) and 4.5% (1.8−7.2)
respectively. Thickness increased more in knees treated with ACL recon-
struction than in knees treated with rehabilitation alone, 5.6% (2.8−8.4)
and 1.6% (−1.3−4.4), respectively. In TrF, mean measures decreased
(−0.430<SRM>−0.133). AC of TrF decreased (2.7%, 1.2−4.2) in knees
treated with ACL reconstruction but increased (1.2%, −0.4−2.7) in those
treated with rehabilitation alone (Table 1).
Conclusions: Cartilage hypertrophy of cMF, indicated by increased ThC-
cAB and VC, occurs during the ﬁrst 24 months after ACL injury. An early
ACL reconstruction appears to be associated with morphometric change
of cartilage in cMF and TrF after 2 years, where SRMs close to 1 were
observed.
Table 1: Mean change of cartilage surface area (AC), thickness (ThCcAB) and volume (VC)
between 3 and 24 months
All subjects (N=29) Rehab alone (n = 10) ACL reconstruction (n = 19)
Change mean
(95%CI)
Change %
mean
(95%CI)
SRM Change mean
(95%CI)
SRM Change mean
(95%CI)
SRM
AC (mm2)
cMF 1.8
(−11.5, 15.0)
0.4
(−1.1, 1.8)
0.052 −3.7
(−26.9, 19.6)
−0.114 4.6
(−13.0, 22.2)
0.126
TrF −32.0
(−60.3, −3.7)
−1.4
(−2.6, −0.1)
−0.430 24.0
(−6.4, 54.3)
0.566 −61.4
(−95.6, −27.1)
−0.864
ThCcAB (mm)
cMF 0.09
(0.04, 0.14)
4.2
(2.1, 6.3)
0.750 0.03
(−0.03, 0.1)
0.333 0.12
(0.06, 0.18)
0.923
TrF −0.02
(−0.08, 0.04)
−0.5
(−2.9, 1.8)
−0.133 0.02
(−0.02, 0.07)
0.286 −0.04
(−0.13, 0.04)
−0.235
VC (mm3)
cMF 65.4
(17.8, 113.0)
4.5
(1.8, 7.2)
0.522 16.0
(−39.0, 71.1)
0.208 91.4
(24.3, 158.4)
0.657
TrF −88.5
(−215.0, 37.9)
−1.2
(−3.9, 1.5)
−0.267 71.1
(−27.3, 169.5)
0.517 −172.6
(−353.4, 8.3)
−0.460
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Purpose: Although hypertrophic differentiation of chondrocytes is a cru-
cial step not only for physiological skeletal growth but also for pathological
disorders like osteoarthritis, the underlying molecular mechanism remains
unclear. This study investigated the role of CCAAT/enhancer-binding
protein b (C/EBPb), a multi-functional transcription factor, in chondrocytes
during endochondral ossiﬁcation.
Methods: To clarify the physiological function of C/EBPb, we initially
compared the skeletal phenotypes of homozygous C/EBPb-deﬁcient
(C/EBPb−/−) mice with those of the wild-type littermates (E16.5) by
Alizarin red, Alcian blue, von Kossa stainings, as well as type X collagen
(COL10) immunostaining and BrdU labeling. We further compared the
proliferation and hypertrophic differentiation in cultures of primary chon-
drocytes derived from ribs of the two genotype littemates by XTT assay,
real-time RT-PCR for COL10, MMP-13, VEGF, and ALP and Alizarin red
stainings. We also compared the same parameters between cultured
wild-type rib chondrocytes with retroviral overexpression of C/EBPb and
the control empty vector. The effect of the C/EBPb overexpression on
cell cycle was examined by a DNA histogram using a ﬂow cytometric
analysis. Identiﬁcation of transcriptional targets of C/EBPb was performed
by a microarray analysis, and was conﬁrmed by real-time RT-PCR. In
vivo expressions of C/EBPb and the target factor were examined by
immunohistochemistry in the mouse growth plates. Transcriptional activity
was examined using HuH-7 cells transfected with a luciferase-reporter
gene construct containing a 1 kb fragment of the promoter. The speciﬁc
binding of the identiﬁed region was veriﬁed by electrophoretic mobility shift
assay (EMSA). Functional relevance was examined by gene silencing by
the small interfering RNA (siRNA).
Results: The C/EBPb−/− mice exhibited dwarﬁsm with an elongated
proliferative zone and delayed chondrocyte hypertrophy in the growth
plate cartilage. The loss- and gain-of-functions of C/EBPb in cultured
chondrocytes revealed that C/EBPb was essential for suppression of
cell proliferation and promotion of hypertrophic differentiation, probably
by accelerating the exit from the cell cycle. The C/EBPb overexpression
caused accumulation of cells in the G0/G1 fraction, and a microarray
analysis identiﬁed several cell cycle factors as the transcriptional targets.
Among them, p57Kip2, a cyclin-dependent kinase inhibitor, was most
strongly up-regulated by the C/EBPb overexpression and down-regulated
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by the C/EBPb diﬁciency in the chondrocytes. p57 was co-localized with
C/EBPb in late proliferative and pre-hypertrophic chondrocytes of the
growth plate, which was dramatically decreased by the C/EBPb deﬁciency.
The promoter activity of p57 was enhanced by C/EBPb transfection.
Deletion, mutagenesis, and tandem-repeat analyses of the luciferase
assay identiﬁed the core responsive element to be between the −150
and −130 bp region containing a putative C/EBP-binding motif. EMSA
revealed the binding of C/EBPb-overexpressed nuclear extracts with the
oligonucleotide including this region, whose speciﬁcity was veriﬁed by the
C/EBPb antibody supershift. The knockdown of p57 by the siRNA inhib-
ited the C/EBPb-induced hypertrophic differentiation in cultured chondro-
cytes.
Conclusions: C/EBPb directly transactivates p57 at a speciﬁc C/EBP
motif to promote transition from proliferation to hypertrophic differentiation
of chondrocytes during skeletal growth, indicating the essential role of the
C/EBPb/p57 signal during endochondral ossiﬁcation.
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Purpose: Mitochondria are involved in many cellular processes, and
mitochondrial dysfunctions have been associated with apoptosis, aging
and a number of pathological conditions, including osteoarthritis (OA).
Therefore, mitochondrial proteins are an attractive target to study the
metabolism of chondrocyte and its role in cartilage degradation. We
aimed in this work to analyze the mitochondrial protein changes that
are characteristic of OA chondrocytes, and identify a new OA-related
mitochondrial protein proﬁle.
Methods: Chondrocytes were obtained from OA patients undergoing
joint replacement, and cartilages from autopsies without history of joint
disease. Mitochondria were isolated by differential centrifugation pro-
cesses. Protein proﬁling was carried out using the differential in-gel
electrophoresis technology (DIGE). Brieﬂy, mitochondrial proteins from
control and OA samples were labelled with different ﬂuorescent dyes and
co-resolved by 2D gel electrophoresis using a pool of all samples as
internal standard. Biological variation analysis, statistics and hierarchical
clustering were performed using DeCyder software. OA-related proteins
were identiﬁed by MALDI-TOF/TOF mass spectrometry. Validation of
the results was carried out by real-time PCR, Western blotting and
immunoﬂuorescence analyses. Pathway analysis was performed using
PathwayStudio software.
Results: We examined more than 1500 protein spots that were present
in the six different DIGE gels. Both qualitative and quantitative changes
in protein abundance patterns were studied, considering changes within
95% conﬁdence interval and standardized average ratios exceeding 1.3
in at least four of the six analyzed gels. 28 protein spots were found
to be increased in OA cells, including the TNFa-receptor-associated
protein and two subunits of the mitochondrial respiratory chain com-
plex I. On the other hand, 45 protein spots were decreased in OA
chondrocytes, including two mitoﬁlin and two mitochondrial superoxide
dismutase (MnSOD, ratio −1.6, p =0.0024) forms. Unsupervised Princi-
pal Component Analysis and hierarchical clustering (HCA) of these 73
differentially present proteins – 22 of them which were previously deﬁned
as mitochondrial (Figure 1) – allowed the deﬁnition of two different protein
proﬁles corresponding to OA and control samples. Network analysis
was accomplished to evaluate the biological functions affected by this
chondrocyte mitochondrial dysregulation in OA. Validation of the results
was performed for MnSOD by western blot and real time PCR on OA
and normal chondrocyte protein extracts. We also found MnSOD protein
levels signiﬁcantly decreased in osteoarthritic cartilage superﬁcial layer
when compared to control.
Conclusions: This study describes the differences between the mito-
chondrial protein proﬁles of normal and OA chondrocytes, evidencing the
mitochondrial dysregulation that takes place during cartilage degradation
in osteoarthritis. Reduction of MnSOD in OA chondrocytes suggests a
decreased antioxidant activity of cartilage cells that might contribute to
tissue degradation.
Figure 1. Mitochondrial proteins altered in OA. A: Proteome map indi-
cating those mitochondrial proteins that exhibit differences in abundance
when compared to control. B: Unsupervised hierarchical clustering of
the 22 identiﬁed mitochondrial proteins, indicating the variations in abun-
dance.
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Purpose: Evidence suggests that cell aging or senescence is impor-
tant in the pathogenesis of osteoarthritis (OA). Indeed, by analogy to
neurodegenerative disorders, OA has been termed by Aigner as the
“M. Alzheimer” of articular cartilage. In certain forms of progeria, a defect
in lamin A processing leads to accelerated aging of mesenchymal tissues,
and development of OA at a very young age. In the current study, we
report that OA chondrocytes accumulate lamin A, leading to activation of
caspase 3 and mitochondrial dysfunction.
Methods: Human OA cartilage samples and chondrocytes were isolated
from patients undergoing knee replacement surgery as approved by IRB.
Standard Western Blot, ﬂuorescent microscopy, and Q-PCR techniques
were used. Anti-human lamin A antibody was purchased from Abcam
Inc. TUNEL staining (Roche), ATP Bioluminescence assays (Sigma), and
activated caspase 3 assays (R&D) were performed per manufacturer’s
recommendations.
Results: Lamin A expression was markedly increased (immuno blot) in
chondrocytes derived from OA cartilage samples (n = 6) when compared
with age matched healthy controls (n = 4). Q-PCR analysis demonstrated
a signiﬁcant increase in the Lamin A: Lamin B mRNA ratio in the OA
samples (2.9±0.4 in healthy controls vs. 7.2±1.7 in OA subjects). Since
Il-1b and PGE2 are catabolic mediators, which have been shown to
promote apoptosis in OA chondrocytes, we explored their effects on lamin
A expression. Il-1b caused little to no change in lamin A expression. In
contrast the exposure of chondrocytes to PGE2 (10 uM) caused a marked
increased lamin A accumulation (Western blot) in a rimmed pattern
around the nucleus (confocal microscopy), as well as an increase in
lamin A:lamin B mRNA ration (Q-PCR). This pattern of increased protein
expression and lamin A:lamin B mRNA mimicked that observed in OA
cartilage, suggesting that PGE2 augments lamin A expression via post-
translational mechanisms. These effects by exogenous PGE2 on lamin A
expression were blocked by antagonists of the EP2 receptor, but not
